Log in to save to my catalogue

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical tria...

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical tria...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1428768bef3040f9ab20ab19592abf68

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

About this item

Full title

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

Publisher

England: BioMed Central Ltd

Journal title

Respiratory research, 2020-09, Vol.21 (1), p.240-240, Article 240

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Chronic obstructive pulmonary disease (COPD) is characterised by progressive airflow limitation and chronic inflammation. Predicting exacerbations of COPD, which contribute to disease progression, is important to guide preventative treatment and improve outcomes. Blood eosinophils are a biomarker for patient responsiveness to inhaled corticosteroid...

Alternative Titles

Full title

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1428768bef3040f9ab20ab19592abf68

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1428768bef3040f9ab20ab19592abf68

Other Identifiers

ISSN

1465-993X,1465-9921

E-ISSN

1465-993X,1465-9921

DOI

10.1186/s12931-020-01482-1

How to access this item